NCT00003399View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

carmustine

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

dexamethasone

DRUG

etoposide

DRUG

melphalan

DRUG

paclitaxel

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00003399 - Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter